56.98
price up icon2.76%   1.53
after-market アフターアワーズ: 57.00 0.02 +0.04%
loading
前日終値:
$55.45
開ける:
$56.71
24時間の取引高:
17.78M
Relative Volume:
1.22
時価総額:
$193.17B
収益:
$45.44B
当期純損益:
$16.18B
株価収益率:
15.68
EPS:
3.634
ネットキャッシュフロー:
$9.21B
1週間 パフォーマンス:
+8.72%
1か月 パフォーマンス:
-14.68%
6か月 パフォーマンス:
-35.31%
1年 パフォーマンス:
-58.37%
1日の値動き範囲:
Value
$56.64
$57.51
1週間の範囲:
Value
$53.74
$57.51
52週間の値動き範囲:
Value
$45.05
$139.74

Novo Nordisk Adr Stock (NVO) Company Profile

Name
名前
Novo Nordisk Adr
Name
セクター
Healthcare (1157)
Name
電話
-
Name
住所
-
Name
職員
78,387
Name
Twitter
@novonordisk
Name
次回の収益日
2024-12-06
Name
最新のSEC提出書
Name
NVO's Discussions on Twitter

NVO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
56.98 238.83B 45.44B 16.18B 9.21B 3.634
Drug Manufacturers - General icon
LLY
Lilly Eli Co
711.68 625.77B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
179.29 424.47B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
210.60 364.92B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
126.98 240.07B 53.40B 13.68B 16.89B 6.9231
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.37 210.36B 63.43B 16.42B 14.72B 6.49

Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-13 アップグレード BNP Paribas Exane Underperform → Neutral
2025-08-05 ダウングレード UBS Buy → Neutral
2025-07-31 ダウングレード HSBC Securities Buy → Hold
2025-07-30 ダウングレード Barclays Overweight → Equal Weight
2025-04-17 ダウングレード BMO Capital Markets Outperform → Market Perform
2025-03-13 アップグレード Kepler Hold → Buy
2025-03-03 ダウングレード Stifel Buy → Hold
2025-02-12 開始されました Morgan Stanley Equal-Weight
2025-01-06 アップグレード Bernstein Underperform → Mkt Perform
2024-05-30 開始されました Goldman Buy
2024-04-12 開始されました BMO Capital Markets Outperform
2024-01-23 開始されました Morgan Stanley Overweight
2024-01-16 再開されました UBS Neutral
2023-12-01 開始されました Cantor Fitzgerald Overweight
2023-10-02 開始されました Argus Buy
2023-07-14 開始されました HSBC Securities Buy
2022-07-15 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-06-28 ダウングレード UBS Neutral → Sell
2022-06-27 アップグレード Exane BNP Paribas Underperform → Neutral
2022-06-07 アップグレード JP Morgan Neutral → Overweight
2022-05-31 アップグレード Guggenheim Neutral → Buy
2022-04-25 アップグレード Cowen Market Perform → Outperform
2022-04-12 アップグレード Morgan Stanley Underweight → Equal-Weight
2022-03-16 アップグレード Deutsche Bank Hold → Buy
2022-01-25 ダウングレード Liberum Hold → Sell
2021-12-20 ダウングレード JP Morgan Overweight → Neutral
2021-12-17 ダウングレード Deutsche Bank Buy → Hold
2021-01-20 ダウングレード Credit Suisse Outperform → Neutral
2021-01-15 開始されました Deutsche Bank Buy
2020-09-29 開始されました Berenberg Hold
2020-07-06 ダウングレード BofA Securities Buy → Neutral
2020-05-11 ダウングレード UBS Buy → Neutral
2020-05-04 開始されました Cowen Market Perform
2020-03-16 アップグレード BofA/Merrill Neutral → Buy
2020-01-03 ダウングレード Guggenheim Buy → Neutral
2019-11-18 アップグレード Barclays Equal Weight → Overweight
2019-09-17 アップグレード Citigroup Neutral → Buy
2019-08-30 ダウングレード Jefferies Hold → Underperform
2019-06-20 ダウングレード Deutsche Bank Buy → Hold
2019-06-11 アップグレード Barclays Underweight → Equal Weight
2019-04-29 アップグレード Credit Suisse Neutral → Outperform
2019-01-29 開始されました Exane BNP Paribas Outperform
2018-12-11 再開されました Jefferies Hold
2018-10-09 開始されました Guggenheim Buy
2017-12-29 アップグレード JP Morgan Underweight → Neutral
2017-12-06 アップグレード BofA/Merrill Neutral → Buy
2017-12-01 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-09-25 ダウングレード Exane BNP Paribas Outperform → Neutral
2017-09-06 アップグレード BofA/Merrill Underperform → Neutral
すべてを表示

Novo Nordisk Adr (NVO) 最新ニュース

pulisher
Aug 20, 2025

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.

Aug 20, 2025
pulisher
Aug 20, 2025

HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Aug 20, 2025
pulisher
Aug 20, 2025

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Aug 20, 2025
pulisher
Aug 20, 2025

Using data models to predict Novo Nordisk A s (b Shares) Adrhedged stock movementBuy Signal & Weekly Stock Performance Updates - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Reversal indicators forming on Novo Nordisk A s (b Shares) Adrhedged stockJuly 2025 Action & Daily Growth Stock Investment Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can momentum traders help lift Novo Nordisk A s (b Shares) Adrhedged2025 Stock Rankings & Long-Term Safe Investment Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Novo Nordisk A s (b Shares) Adrhedged showing signs of accumulationJuly 2025 Institutional & Low Risk Entry Point Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Novo Nordisk A s (b Shares) Adrhedged still worth holding after the dipTrade Risk Assessment & Consistent Growth Equity Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Does Novo Nordisk A s (b Shares) Adrhedged fit your quant trading modelMarket Trend Summary & Detailed Earnings Play Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Novo Nordisk A s (b Shares) Adrhedged stock ready for a breakoutMarket Risk Report & Verified Short-Term Plans - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

What moving averages say about Novo Nordisk A s (b Shares) Adrhedged2025 Top Gainers & Community Verified Swing Trade Signals - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What’s next for Novo Nordisk A s (b Shares) Adrhedged stock priceEarnings Recap Report & Expert Approved Momentum Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Earnings visualization tools for Novo Nordisk A s (b Shares) AdrhedgedChart Signals & Precise Entry and Exit Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using portfolio simulators with Novo Nordisk A s (b Shares) Adrhedged includedJuly 2025 Catalysts & Verified Momentum Stock Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Novo Nordisk shares rise 1.58% premarket after board member Christina Law's ADR purchase. - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - The Manila Times

Aug 19, 2025
pulisher
Aug 19, 2025

Novo Nordisk Board Member Christina Law Buys $0.8 Million in ADRs - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Novo Nordisk Board Member Christina Law Purchases ADRs Worth DKK 0.8 Million - MarketScreener

Aug 19, 2025
pulisher
Aug 19, 2025

Technical signs of recovery in Novo Nordisk A s (b Shares) AdrhedgedPortfolio Risk Report & Real-Time Stock Entry Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Novo Nordisk A s (b Shares) Adrhedged stock prediction for this weekJuly 2025 Final Week & Pattern Based Trade Signal System - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Glenn Jorgensen @Glennjdk: "𝐖𝐞 𝐡𝐚𝐝 𝐦𝐨𝐫𝐞 𝐍𝐨𝐯𝐨 𝐍𝐨𝐫𝐝𝐢𝐬𝐤..." - eToro

Aug 19, 2025
pulisher
Aug 19, 2025

Using data filters to optimize entry into Novo Nordisk A s (b Shares) Adrhedged2025 Top Decliners & Technical Entry and Exit Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How to monitor Novo Nordisk A s (b Shares) Adrhedged with trend dashboards2025 Winners & Losers & Detailed Earnings Play Strategies - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

AI Trend Models Suggest Bounce for Novo Nordisk A s (b Shares) AdrhedgedMarket Weekly Review & AI Driven Price Predictions - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Is Novo Nordisk A s (b Shares) Adrhedged trending in predictive chart modelsWeekly Investment Recap & Fast Gain Stock Trading Tips - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Applying sector rotation models to Novo Nordisk A s (b Shares) AdrhedgedIndex Update & Fast Exit/Entry Strategy Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to forecast Novo Nordisk A s (b Shares) Adrhedged trends using time seriesMarket Sentiment Report & Long-Term Safe Investment Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Novo Nordisk A s (b Shares) Adrhedged Stock a Smart Buy in 2025 Investment Analysis Inside - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Chart based exit strategy for Novo Nordisk A s (b Shares) AdrhedgedJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.

Aug 17, 2025
pulisher
Aug 17, 2025

Full technical analysis of Novo Nordisk A s (b Shares) Adrhedged stockNew Guidance & High Conviction Investment Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Why Novo Nordisk A s (b Shares) Adrhedged stock attracts strong analyst attentionDollar Strength & Pattern Based Trade Signal System - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Price action breakdown for Novo Nordisk A s (b Shares) AdrhedgedWeekly Trade Recap & Free High Return Stock Watch Alerts - Newser

Aug 16, 2025

Novo Nordisk Adr (NVO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general MRK
$87.37
price up icon 1.50%
$293.72
price down icon 0.69%
drug_manufacturers_general PFE
$25.88
price up icon 0.54%
$114.77
price down icon 1.18%
drug_manufacturers_general SNY
$51.35
price up icon 1.46%
大文字化:     |  ボリューム (24 時間):